Case number 2019-1924
Eagle Pharmaceuticals Inc. v. Slayback Pharma LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 4, 2021 | 0 | EAGLE PHARMACEUTICALS INC. v. SLAYBACK PHARMA LLC [OPINION] [precedential] (0) |
| Oct 4, 2021 | 0 | EAGLE PHARMACEUTICALS INC. v. SLAYBACK PHARMA LLC [ERRATA] [nonprecedential] (0) |
| Jun 15, 2020 | 61 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [701052] [JAB] [Entered: 06/15/2020 11:21 AM] (1) |
| May 12, 2020 | 60 | ERRATA to the Precedential Opinion [56]. Service as of this date by the Clerk of Court. [693803] [JAB] [Entered: 05/12/2020 09:57 AM] (1) |
| May 12, 2020 | 59 | ORDER filed granting motion to correct/supplement [58] filed by Appellee Slayback Pharma LLC. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [693801] [JAB] [Entered: 05/12/2020 09:55 AM] (2) |
| May 8, 2020 | 58 | MOTION of Appellee Slayback Pharma LLC to correct or supplement [Consent: unopposed]. Service: 05/08/2020 by email. [693330] [19-1924] [Constance Huttner] [Entered: 05/08/2020 05:53 PM] (7) |
| May 8, 2020 | 57 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [693038] [JAB] [Entered: 05/08/2020 09:43 AM] (1) |
| May 8, 2020 | 56 | OPINION filed for the court by O'Malley, Circuit Judge; Reyna, Circuit Judge and Chen, Circuit Judge. Precedential Opinion. [693037] [JAB] [Entered: 05/08/2020 09:42 AM] (11) |
| Mar 4, 2020 | 55 | Submitted after ORAL ARGUMENT by Daniel Brown for Eagle Pharmaceuticals Inc. and Constance Huttner for Slayback Pharma LLC. Panel: Judge: O'Malley , Judge: Reyna , Judge: Chen. [676136] [JCP] [Entered: 03/04/2020 10:59 AM] (0) |
| Feb 14, 2020 | 54 | Response to notice of oral argument from the Appellant Eagle Pharmaceuticals Inc.. [671531] [19-1924] [Daniel Brown] [Entered: 02/14/2020 01:28 PM] (3) |
| Feb 13, 2020 | 53 | Response to notice of oral argument from the Appellee Slayback Pharma LLC. [671243] [19-1924] [Constance Huttner] [Entered: 02/13/2020 09:50 PM] (3) |
| Jan 21, 2020 | 52 | NOTICE OF ORAL ARGUMENT. Panel: 2003H. Case scheduled March 4, 2020 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 402. Response to Notice of Oral Argument due: 02/14/2020. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [664642] [JAB] [Entered: 01/21/2020 01:32 PM] (2) |
| Oct 23, 2019 | 51 | The following conflict dates submitted by Attorney Constance Huttner for Appellee Slayback Pharma LLC have been accepted by the court: 01/06/2020, 01/07/2020, 01/08/2020, 01/09/2020, 01/10/2020, 04/08/2020, 04/09/2020, 04/10/2020. [644036] [JAB] [Entered: 10/23/2019 08:04 AM] (0) |
| Oct 22, 2019 | 50 | Notice from Appellee Slayback Pharma LLC regarding conflicts with oral argument. Service: 10/22/2019 by email. [643968] [19-1924] [Constance Huttner] [Entered: 10/22/2019 03:57 PM] (3) |
| Oct 22, 2019 | 49 | The following conflict dates submitted by Attorney Daniel Brown for Appellant Eagle Pharmaceuticals Inc. have been accepted by the court: 01/06/2020, 01/07/2020, 01/08/2020, 01/09/2020, 01/10/2020. [643936] [JAB] [Entered: 10/22/2019 03:13 PM] (0) |
| Oct 22, 2019 | 48 | Notice from Appellant Eagle Pharmaceuticals Inc. regarding conflicts with oral argument. Service: 10/22/2019 by email. [643924] [19-1924] [Daniel Brown] [Entered: 10/22/2019 03:00 PM] (3) |
| Oct 18, 2019 | 47 | 6 paper copies of the Corrected Confidential Opening Response Brief [34] received from Appellee Slayback Pharma LLC. [643891] [CJF] [Entered: 10/22/2019 02:26 PM] (0) |
| Oct 17, 2019 | 46 | 6 paper copies of the Confidential Joint Appendix Brief [40] received from Appellant Eagle Pharmaceuticals Inc.. [643005] [CJF] [Entered: 10/18/2019 07:27 AM] (0) |
| Oct 16, 2019 | 45 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [642594] [JAL] [Entered: 10/16/2019 01:38 PM] (1) |
| Oct 16, 2019 | 44 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [642593] [JAL] [Entered: 10/16/2019 01:38 PM] (0) |
| Oct 15, 2019 | 43 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Slayback Pharma LLC. Service: 10/15/2019 by email. [642482] [19-1924] [Beth Finkelstein] [Entered: 10/15/2019 07:20 PM] (3) |
| Oct 15, 2019 | 42 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Eagle Pharmaceuticals Inc. and Appellee Slayback Pharma LLC. Service: 10/15/2019 by email. [642470] [19-1924] [Daniel Brown] [Entered: 10/15/2019 06:21 PM] (4) |
| Oct 15, 2019 | 41 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Eagle Pharmaceuticals Inc.. Service: 10/15/2019 by email. [642469] [19-1924] [Daniel Brown] [Entered: 10/15/2019 06:16 PM] (3) |
| Oct 15, 2019 | 40 | MODIFIED ENTRY: CONFIDENTIAL JOINT APPENDIX FILED for Appellant Eagle Pharmaceuticals Inc. Number of Pages: 237. Service: 10/15/2019 by email. [642465]--[Edited 10/16/2019 by JAL - Compliance review complete] [Daniel Brown] [Entered: 10/15/2019 06:03 PM] (0) |
| Oct 15, 2019 | 39 | MODIFIED ENTRY: JOINT APPENDIX FILED for Appellant Eagle Pharmaceuticals Inc. Number of Pages: 195. Service: 10/15/2019 by email. [642461] --[Edited 10/16/2019 by JAL - Compliance review complete] [Daniel Brown] [Entered: 10/15/2019 05:51 PM] (195) |
| Oct 10, 2019 | 38 | 6 paper copies of the Confidential Reply Brief [37] received from Appellant Eagle Pharmaceuticals Inc.. [641511] [CJF] [Entered: 10/10/2019 11:16 AM] (0) |
| Oct 8, 2019 | 37 | MODIFIED ENTRY: CONFIDENTIAL REPLY BRIEF FILED for Appellant Eagle Pharmaceuticals Inc. Number of Pages: 27. Service: 10/08/2019 by email. [641181]--[Edited 10/09/2019 by JAL - Compliance review complete] [Daniel Brown] [Entered: 10/08/2019 08:59 PM] (0) |
| Oct 8, 2019 | 36 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellant Eagle Pharmaceuticals Inc. Number of Pages: 27. Service: 10/08/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [641179] --[Edited 10/09/2019 by JAL - Compliance review complete] [Daniel Brown] [Entered: 10/08/2019 08:51 PM] (36) |
| Oct 8, 2019 | 35 | Amended Certificate of Interest for Appellant Eagle Pharmaceuticals Inc.. Service: 10/08/2019 by email. [641177] [19-1924] [Daniel Brown] [Entered: 10/08/2019 08:39 PM] (3) |
| Sep 6, 2019 | 30 | FILED from Appellee Slayback Pharma LLC. Title: CORRECTED CONFIDENTIAL RESPONSE BRIEF. Service: 09/06/2019 by email. [633662] [19-1924] This document is non-compliant. See Doc No.[33] [Beth Finkelstein] [Entered: 09/06/2019 01:17 PM] (0) |
| Sep 6, 2019 | 31 | MODIFIED ENTRY: CORRECTED RESPONSE BRIEF FILED for Appellee Slayback Pharma LLC. Number of Pages: 35. Service: 09/06/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of the original version of this brief [26]. See Fed. Cir. R. 31. [633663] --[Edited 09/06/2019 by JAL - Compliance review complete] [Beth Finkelstein] [Entered: 09/06/2019 01:19 PM] (46) |
| Sep 6, 2019 | 32 | **TEXT ONLY** ORDER granting motion to extend time to file brief [28] filed by Appellant Eagle Pharmaceuticals Inc. The reply brief is due 10/08/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [633673] [JAL] [Entered: 09/06/2019 01:48 PM] (0) |
| Sep 6, 2019 | 33 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Slayback Pharma LLC, Corrected Confidential Response Brief [30], is not in compliance with the rules of this court (see attached). Compliant document is due on 09/13/2019. The deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [633695] [JAL] [Entered: 09/06/2019 02:24 PM] (1) |
| Sep 6, 2019 | 34 | MODIFIED ENTRY: CORRECTED CONFIDENTIAL RESPONSE BRIEF FILED for Appellee Slayback Pharma LLC. Number of Pages: 35. Service: 09/06/2019 by US mail. [633730]--[Edited 09/06/2019 by JAL - Compliance review complete] [Beth Finkelstein] [Entered: 09/06/2019 03:03 PM] (0) |
| Sep 6, 2019 | 29 | Amended Certificate of Interest for Appellee Slayback Pharma LLC. Service: 09/06/2019 by email. [633661] [19-1924] [Beth Finkelstein] [Entered: 09/06/2019 01:14 PM] (3) |
| Sep 5, 2019 | 28 | MOTION of Appellant Eagle Pharmaceuticals Inc. to extend the time to 10/08/2019 to file the Reply Brief. [Consent: unopposed]. Service: 09/05/2019 by email. [633366] [19-1924] [Daniel Brown] [Entered: 09/05/2019 12:43 PM] (6) |
| Sep 5, 2019 | 27 | NOTICE OF NON-COMPLIANCE: The submissions of Appellee Slayback Pharma LLC, Confidential Response Brief and Response Brief [25], [26], are not in compliance with the rules of this court (see attached). Compliant documents are due on 09/12/2019. The deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [633306] [JAL] [Entered: 09/05/2019 11:20 AM] (2) |
| Sep 3, 2019 | 26 | FILED from Appellee Slayback Pharma LLC. Title: RESPONSE BRIEF. Service: 09/03/2019 by email. [632893] [19-1924] This document is non-compliant. See Doc No.[27] [Beth Finkelstein] [Entered: 09/03/2019 05:37 PM] (46) |
| Sep 3, 2019 | 25 | FILED from Appellee Slayback Pharma LLC. Title: CONFIDENTIAL RESPONSE BRIEF. Service: 09/03/2019 by US mail. [632891] [19-1924] This document is non-compliant. See Doc No.[27]--[Edited 09/06/2019 by JAL to correct docket text] [Beth Finkelstein] [Entered: 09/03/2019 05:36 PM] (0) |
| Sep 3, 2019 | 24 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.3 to promptly submit an amended Entry of Appearance as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [632653] [JAL] [Entered: 09/03/2019 11:25 AM] (0) |
| Sep 3, 2019 | 23 | Entry of appearance for Andrew J. Miller as of counsel for Appellee Slayback Pharma LLC. Service: 09/03/2019 by email. [632646] [19-1924] [Beth Finkelstein] [Entered: 09/03/2019 11:08 AM] (2) |
| Aug 30, 2019 | 22 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.3 to promptly submit an amended Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [632358] [JAL] [Entered: 08/30/2019 01:44 PM] (0) |
| Aug 30, 2019 | 21 | Corrected Entry of appearance for Constance S. Huttner as principal counsel for Appellee Slayback Pharma LLC. Service: 08/30/2019 by email. [632252] [19-1924] [Beth Finkelstein] [Entered: 08/30/2019 11:13 AM] (2) |
| Aug 30, 2019 | 20 | Amended Entry of appearance for James P. Barabas as of counsel for Appellee Slayback Pharma LLC. Service: 08/30/2019 by email. [632248] [19-1924] [Beth Finkelstein] [Entered: 08/30/2019 11:08 AM] (2) |
| Aug 30, 2019 | 19 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Slayback Pharma LLC, Entry of Appearance - C. Huttner [18], is not in compliance with the rules of this court (see attached). Compliant document is due on 09/09/2019. Service as of this date by the Clerk of Court. [632189] [JAL] [Entered: 08/30/2019 09:26 AM] (1) |
| Aug 29, 2019 | 18 | Entry of appearance for Constance S. Huttner as principal counsel for Appellee Slayback Pharma LLC. Service: 08/29/2019 by email. [632106] [19-1924] This document is non-compliant. See Doc No.[19] [Beth Finkelstein] [Entered: 08/29/2019 05:10 PM] (2) |
| Aug 29, 2019 | 17 | Entry of appearance for Beth Finkelstein as of counsel for Appellee Slayback Pharma LLC. Service: 08/29/2019 by email. [632105] [19-1924] [Beth Finkelstein] [Entered: 08/29/2019 05:08 PM] (2) |
| Jul 31, 2019 | 16 | 6 paper copies of the Confidential Opening Brief [15] received from Appellant Eagle Pharmaceuticals Inc.. [624757] [CJF] [Entered: 07/31/2019 09:54 AM] (0) |
| Jul 23, 2019 | 15 | MODIFIED ENTRY: CONFIDENTIAL OPENING BRIEF FILED for Appellant Eagle Pharmaceuticals Inc. Number of Pages: 49. Service: 07/23/2019 by email. [623022]--[Edited 07/29/2019 by JAL - Compliance review complete] [Daniel Brown] [Entered: 07/23/2019 11:11 PM] (0) |
| Jul 23, 2019 | 14 | MODIFIED ENTRY: OPENING BRIEF FILED for Appellant Eagle Pharmaceuticals Inc. Number of Pages: 49. Service: 07/23/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [623021] --[Edited 07/29/2019 by JAL - Compliance review complete] [Daniel Brown] [Entered: 07/23/2019 11:05 PM] (88) |
| Jul 23, 2019 | 13 | Entry of appearance for Gregory K. Sobolski as of counsel for Appellant Eagle Pharmaceuticals Inc.. Service: 07/23/2019 by email. [622828] [19-1924] [Gregory Sobolski] [Entered: 07/23/2019 11:01 AM] (3) |
| Jul 5, 2019 | 12 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [619328] [JAL] [Entered: 07/05/2019 03:47 PM] (0) |
| Jun 11, 2019 | 11 | Filing fee paid in the United States District Court for the District of Delaware on 05/23/2019. [613221] [JAL] [Entered: 06/11/2019 03:18 PM] (0) |
| Jun 7, 2019 | 10 | Docketing Statement for the Appellee Slayback Pharma LLC. Service: 06/07/2019 by email. [612583] [19-1924] [James Barabas] [Entered: 06/07/2019 05:38 PM] (4) |
| Jun 7, 2019 | 9 | Certificate of Interest for the Appellee Slayback Pharma LLC. Service: 06/07/2019 by email. [612578] [19-1924] [James Barabas] [Entered: 06/07/2019 05:34 PM] (3) |
| Jun 7, 2019 | 8 | Entry of appearance for James P. Barabas as principal counsel for Appellee Slayback Pharma LLC. Service: 06/07/2019 by email. [612576] [19-1924] [James Barabas] [Entered: 06/07/2019 05:31 PM] (2) |
| Jun 7, 2019 | 7 | Entry of appearance for Marc N. Zubick as of counsel for Appellant Eagle Pharmaceuticals Inc.. Service: 06/07/2019 by email. [612497] [19-1924] [Marc Zubick] [Entered: 06/07/2019 03:16 PM] (3) |
| Jun 7, 2019 | 6 | Entry of appearance for Kenneth G. Schuler as of counsel for Appellant Eagle Pharmaceuticals Inc.. Service: 06/07/2019 by email. [612490] [19-1924] [Kenneth Schuler] [Entered: 06/07/2019 03:13 PM] (3) |
| Jun 7, 2019 | 5 | Entry of appearance for Gabriel K. Bell as of counsel for Appellant Eagle Pharmaceuticals Inc.. Service: 06/07/2019 by email. [612486] [19-1924] [Gabriel Bell] [Entered: 06/07/2019 03:10 PM] (3) |
| Jun 7, 2019 | 4 | Docketing Statement for the Appellant Eagle Pharmaceuticals Inc.. Service: 06/07/2019 by email. [612480] [19-1924] [Daniel Brown] [Entered: 06/07/2019 03:07 PM] (4) |
| Jun 7, 2019 | 3 | Certificate of Interest for the Appellant Eagle Pharmaceuticals Inc.. Service: 06/07/2019 by email. [612477] [19-1924] [Daniel Brown] [Entered: 06/07/2019 03:05 PM] (3) |
| Jun 7, 2019 | 2 | Entry of appearance for Daniel G. Brown as principal counsel for Appellant Eagle Pharmaceuticals Inc.. Service: 06/07/2019 by email. [612475] [19-1924] [Daniel Brown] [Entered: 06/07/2019 03:02 PM] (3) |
| May 24, 2019 | 1 | Appeal docketed. Received: 05/23/2019. [609661]Fee is due on 06/07/2019. Entry of Appearance is due 06/07/2019. Certificate of Interest is due on 06/07/2019. Docketing Statement is due 06/07/2019. Appellant's brief is due 07/23/2019. [JAL] [Entered: 05/24/2019 04:05 PM] (39) |
